Italy's DiaSorin first quarter revenue up 8%, confirms 2025 guidance

DiaSorin SpA

06/05/2025 17:04

May 6 (Reuters) - Italian medical diagnostics group DiaSorin DIAS.MI said on Tuesday first quarter revenue rose 8 percent at current exchange rates to 313 million euros ($354.88 million), as a "stronger-than-regular" flu season contributed to the positive result of its business lines.

DiaSorin also confirmed its 2025 guidance of an expected increase of around 8 percent in its ex-Covid revenues, with an adjusted core profit margin at around 34 percent, saying the estimated impact of new tariffs measures is "not material" for the group.

($1 = 0.8820 euros)

 (Reporting by Philippe Leroy Beaulieu in Gdansk)

 ((Philippe.LeroyBeaulieu@thomsonreuters.com;))